DHAI (DIH Holding US) EBITDA Margin %: -39.98% (As of Mar. 2025)


What is DIH Holding US EBITDA Margin %?

DIH Holding US DHAI EBITDA Margin % is -39.98% as of Mar. 2025.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. DIH Holding US's EBITDA for the three months ended in Mar. 2025 was $-5.06 Mil. DIH Holding US's Revenue for the three months ended in Mar. 2025 was $12.65 Mil. Therefore, DIH Holding US's EBITDA margin for the quarter that ended in Mar. 2025 was -39.98%.

DIH Holding US  (OTCPK:DHAI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

DIH Holding US EBITDA Margin % Related Terms

DIH Holding US EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for DIH Holding US's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US EBITDA Margin % Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
EBITDA Margin %
-19.28 1.19 -9.62 -11.31

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -9.66 2.13 -20.38 -39.98

DHAI vs ABT, SYK, MDT: EBITDA Margin % Comparison

For the Medical Devices subindustry, DIH Holding US's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DIH Holding US EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where DIH Holding US's EBITDA Margin % falls into.


DIH Holding US EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

DIH Holding US's EBITDA Margin % for the fiscal year that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-7.107/62.864
=-11.31 %

DIH Holding US's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-5.057/12.648
=-39.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -39.98% mean?
DIH Holding US (DHAI) has a EBITDA Margin % of -39.98% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's EBITDA Margin % too high?
DIH Holding US's current EBITDA Margin % is -39.98%.
How does DIH Holding US's EBITDA Margin % compare to ABT and SYK?
DIH Holding US's EBITDA Margin % of -39.98% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DIH Holding US and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DIH Holding US's current EBITDA Margin % is -39.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current EBITDA Margin % of -39.98%. The current EBITDA Margin % is -39.98%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For DIH Holding US (DHAI), the current EBITDA Margin % is -39.98% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.